The beta-adrenoceptor blocking properties of vaninolol yl-aminopropoxy
)-3'-methoxyphenyl]-3-buten-2-one), derived from vanillin, were first
investigated under in vivo and in vitro conditions. Vaninolol (0.1, 0.
5, 1.0 mg/kg, i.v.), as well as propranolol, produced a dose-dependent
bradycardia response and a sustained presser action in urethane-anest
hetized normotensive rats. Vaninolol inhibited the tachycardia effects
induced by (-)isoproterenol, but had no blocking effect on the arteri
al presser responses induced by phenylephrine. These findings suggeste
d that vaninolol possessed beta-adrenergic blocking activity, but was
without alpha-adrenergic blocking activity. In isolated guinea-pig tis
sues, vaninolol antagonized (-)isoproterenol-induced positive inotropi
c and chronotropic effects of the atria and tracheal relaxation respon
ses in a concentration-dependent manner. The parallel shift to the rig
ht of the concentration-response curve of (-)isoproterenol suggested t
hat vaninolol was a beta-adrenoceptor competitive antagonist. The effe
ct of vaninolol was more potent on the atria than on tracheal tissues,
indicating it had some beta(1)-adrenoceptor selectivity. On the other
hand, the order of the hydrophilicity was atenolol much greater than
vaninolol > propranolol. In addition, vaninolol had a mild direct card
iac depression at high concentrations and was without intrinsic sympat
homimetic activity (ISA). Furthermore, binding characteristics of vani
nolol and other beta-adrenoceptor antagonists were evaluated in [H-3]d
ihydroalprenolol binding to guinea-pig ventricular membranes. The orde
r of potency of beta-adrenoceptor antagonists in competing for the bin
ding sites was (-)propranolol much greater than vaninolol greater than
or equal to atenolol. In conclusion, vaninolol was found to be a sele
ctive beta(1)-adrenoceptor antagonist with relatively low lipophilicit
y in comparison with propranolol, devoid of ISA, and had a mild myocar
dial depressant effect.